Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Smoking bans reduce risk of of heart attack in nonsmokers and smokers

Smoking bans are effective at reducing the risk of heart attacks and heart disease associated with exposure to secondhand smoke, says a new report from the Institute of Medicine. The report also confirms there is sufficient evidence that breathing secondhand smoke boosts nonsmokers' risk for heart problems, adding that indirect evidence indicating that even relatively brief exposures could lead to a heart attack is compelling.

19 Oct 2009

CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout

Data presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology highlight effects of baseline characteristics on achievement of serum uric acid (sUA) levels to <6.0 mg/dL and the frequency of flares with ULORIC® (febuxostat) treatment.

19 Oct 2009

Elected officials have no excuse for failing to enact comprehensive smoke-free workplace laws: IOM

A landmark report released today by the Institute of Medicine provides powerful new evidence that elected officials have no excuse for failing to enact comprehensive smoke-free workplace laws. The IOM report concludes smoke-free laws reduce the number of heart attacks and save lives. The report also confirms that there is conclusive scientific evidence that secondhand smoke causes heart disease, including heart attacks, and finds there is compelling evidence that even relatively brief exposure to secondhand smoke can lead to a heart attack.

19 Oct 2009

Counseling program to promote education and lifestyle change in lupus patients

According to a new study by Hospital for Special Surgery investigators presented at the American College of Rheumatology meeting on October 21 in Philadelphia, most lupus patients are not aware that their condition puts them at a higher risk for cardiovascular disease and a counseling program is a valuable way to promote education and lifestyle change.

19 Oct 2009

Asthma is the most common underlying condition associated with H1N1 Swine Flu: CDC Report

Cannabis Science Inc., an emerging pharmaceutical cannabis company, notes a report by epidemiologists at the Centers for Disease Control and Prevention (CDC) saying that, among people hospitalized with severe cases of the pandemic strain of H1N1 Swine Flu, asthma is by far the most common underlying condition associated with he disease.

19 Oct 2009

NFL, NDC launch 'Fuel Up to Play 60' to tackle childhood obesity

The NFL and National Dairy Council (NDC) today launch Fuel Up to Play 60, a new initiative aimed at tackling childhood obesity by giving youth a voice in changing the school nutrition and physical activity environment. The program will reach 36 million youth in 60,000 elementary, middle and high schools during the 2009/2010 school year.

15 Oct 2009

NBC Universal's 'Healthy At NBCU' to connect its health and wellness content with consumers

NBC Universal will unveil a new company-wide initiative today, "Healthy At NBCU," aimed at connecting consumers, employees and marketers with its breadth of health and wellness content. The announcement was made by Lauren Zalaznick, President NBC Universal Women and Lifestyle Entertainment Networks, who is spearheading the initiative.

15 Oct 2009

Genzyme ranked third on the global list for best employers

Genzyme Corporation announced today that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies. Genzyme is ranked third on the global list of 575 companies, the second consecutive year it has achieved this position. Genzyme placed among the top 10 of all biotechnology and pharmaceutical companies in the world for the seventh year in a row.

15 Oct 2009

National Institutes of Health grants $12 million to WCDRC for obesity research

The Miriam Hospital's Weight Control and Diabetes Research Center (WCDRC) recently received six research grants from the National Institutes of Health - totaling more than $12 million in funding - that will support the work of researchers focused on the prevention and treatment of obesity.

15 Oct 2009

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met® (pioglitazone HCl and metformin HCl) as initial therapy reached the study goal of hemoglobin A1c (HbA1c) of less than or equal to 7 percent compared to either component alone.

15 Oct 2009

Protective effect of moderate alcohol intake is related to life-style factors

According a new study of over 3,000 adults aged 70-79, the apparent association between light-to-moderate alcohol consumption and reduced risk of functional decline over time did not hold up after adjustments were made for characteristics related to lifestyle, in particular physical activity, body weight, education, and income.

15 Oct 2009

More than half RCTs do not report vital information about study populations race, says study

A new study recently published online by the American Heart Journal shows that more than half of all randomized clinical trials, or RCTs, for cardiovascular disease are not reporting vital information about the study populations race or ethnicity. NYU School of Medicine researchers found that out of the 156 cardiovascular disease RCTs analyzed, only 35% of trials reported any information on race or ethnicity between 1970 and 2006. From 2000 to 2006, 46% of trials included that information.

15 Oct 2009

European Patent Office to grant two intellectual property patents to Athera Biotechnologies

Athera Biotechnologies AB, an atherosclerosis R&D company developing novel products for treatment and prevention of cardiovascular disease (CVD), announced today that the European Patent Office intends to grant two key patents related to the Company's intellectual property on its two pharmaceutical candidates Annexin A5 and PC-mAb.

14 Oct 2009

VIA Pharmaceuticals receives determination letter from NASDAQ Stock Market

VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on October 9, 2009, it received a determination letter from The NASDAQ Stock Market notifying the Company that the NASDAQ Hearing Panel (the "Panel") has granted the Company's request to remain listed on NASDAQ, subject to the Company demonstrating compliance with the NASDAQ Listing Rules (the "Listing Rules") on or before December 31, 2009 (the "Exception Period").

14 Oct 2009

American Recovery and Reinvestment Act funds to support research in numerous health areas

As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.

14 Oct 2009

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.

14 Oct 2009

NIH awards Gladstone Institute consortium $3.7M for Huntington's disease research

The National Institutes of Health (NIH) has awarded a "Grand Opportunity" grant of $3.7 million to a consortium formed with the Gladstone Institute of Neurological Disease (GIND) and the Taube-Koret Center for Huntington's Disease Research to use stem cell technology to better understand Huntington's disease (HD) and to develop potential therapies.

14 Oct 2009

Kaiser Permanente receives $54 million grant from NIH to conduct health research

14 Oct 2009

Virginia Health Information releases HMO quality and satisfaction reports

Virginia Health Information (VHI), a nonprofit health information company, reports HMO quality and satisfaction reports at www.vhi.org.

13 Oct 2009

AHA: Americans should reduce their calorie intake to combat obesity and cardiovascular disease

Reaching for that chocolate chip cookie? Think twice. The American Heart Association (AHA) just released the strictest guidelines ever for added sugars, recommending Americans limit their diet to 100 calories (6 teaspoons) for women and 150 calories (nine teaspoons) for men each day.

13 Oct 2009

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Smoking bans reduce risk of of heart attack in nonsmokers and smokers

CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout

Elected officials have no excuse for failing to enact comprehensive smoke-free workplace laws: IOM

Counseling program to promote education and lifestyle change in lupus patients

Asthma is the most common underlying condition associated with H1N1 Swine Flu: CDC Report

NFL, NDC launch 'Fuel Up to Play 60' to tackle childhood obesity

NBC Universal's 'Healthy At NBCU' to connect its health and wellness content with consumers

Genzyme ranked third on the global list for best employers

National Institutes of Health grants $12 million to WCDRC for obesity research

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

Protective effect of moderate alcohol intake is related to life-style factors

More than half RCTs do not report vital information about study populations race, says study

European Patent Office to grant two intellectual property patents to Athera Biotechnologies

VIA Pharmaceuticals receives determination letter from NASDAQ Stock Market

American Recovery and Reinvestment Act funds to support research in numerous health areas

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

NIH awards Gladstone Institute consortium $3.7M for Huntington's disease research

Kaiser Permanente receives $54 million grant from NIH to conduct health research

Virginia Health Information releases HMO quality and satisfaction reports

AHA: Americans should reduce their calorie intake to combat obesity and cardiovascular disease

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in